Jan 18, 2021 12:30:00

Is it the purpose of falsifying and disclosing the data of the new corona vaccine stolen by hackers and reducing the reliability of the vaccine?

Information on the new coronavirus vaccine '

BNT162b2 ' jointly developed by American pharmaceutical giant Pfizer and German BioNTech was stolen from EU regulators, and data of BNT162b2 stolen by hackers was partially tampered with and leaked. , It turns out that it is trying to reduce the reliability of BNT162b2.

Cyberattack on EMA --update 5 | European Medicines Agency
https://www.ema.europa.eu/en/news/cyberattack-ema-update-5

Hackers alter stolen regulatory data to sow mistrust in COVID-19 vaccine | Ars Technica
https://arstechnica.com/information-technology/2021/01/hackers-alter-stolen-regulatory-data-to-sow-mistrust-in-covid-19-vaccine/

On December 9, 2020, the European Medicines Agency (EMA), which is responsible for reviewing EU medicines, was attacked by a cyberattack, and some of the documents related to the BNT162b2 approval application were stolen by hackers.

Drug regulators leak information on Pfizer's new corona vaccine after a cyberattack-GIGAZINE

The stolen document was found to have been published on the dark web by Italian cybersecurity firm Yalix. However, on January 15, 2021, the EMA announced that 'some of the published documents have been tampered with' as a follow-up to the case.

EMA has not disclosed the details of what was tampered with, but the data released by the hacker is different from the original data, and the hacker added his own comment.

According to Yarix, the stolen document was posted on the dark web under the title 'Amazing Scam! Evil Pfizer! Fake Vaccine!'. Also, it seems that the post contained a link to a Russian forum.

Regarding this case, EMA said, 'The purpose is to impair the credibility of the vaccine.' The EMA states that 'only grants approval if the benefits of vaccination outweigh the risks' and 'details of the approval process will be published on the official website', justifying as a regulator. Emphasized gender and transparency of the authorization process.

EMA explained that the investigative authorities had already taken the necessary steps in this case and said, 'We will continue to fully support criminal investigations related to data breaches.'